skip to Main Content

ARBs and ACE Inhibitors Could Improve Survival in Pancreatic Cancer

Newsfeed image, light gray text on dark gray background

Pancreatic cancer is an extremely difficult cancer to treat.  Notwithstanding many advancements in our understanding of the biology of pancreatic cancer,  current treatments do not have much of an effect on prognosis.  Unless it’s caught early, which is rare, only about 10% of patients survive five years past diagnosis.

However, new research that is the largest population-based study of this question from Thomas Jefferson University shows that medications commonly prescribed to treat high blood pressure may also improve survival in patients with pancreatic cancer.  The results suggest a broader, prospective clinical trial is needed to confirm the results and potentially change clinical practice.  Read more . . . 


Back To Top